V S Harvey
Overview
Explore the profile of V S Harvey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
1537
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Clevenger J, Pereira G, Wiechmann D, Schmitt N, Harvey V
J Appl Psychol
. 2001 Jun;
86(3):410-7.
PMID: 11419801
Using 3 different samples, the authors assessed the incremental validity of situational judgment inventories (SJIs), relative to job knowledge, cognitive ability, job experience, and conscientiousness, in the prediction of job...
2.
Pal S, Iruela-Arispe M, Harvey V, Zeng H, Nagy J, Dvorak H, et al.
Microvasc Res
. 2000 Aug;
60(2):112-20.
PMID: 10964585
All-trans-retinoic acid (RA) and other retinoids modulate cell growth and differentiation, generally favoring terminal cell differentiation and inhibiting carcinogenesis. Retinoids are also reported to inhibit angiogenesis and endothelial cell migration,...
3.
Pettersson A, Nagy J, Brown L, Sundberg C, Morgan E, Jungles S, et al.
Lab Invest
. 2000 Feb;
80(1):99-115.
PMID: 10653008
Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) is an angiogenic cytokine with potential for the treatment of tissue ischemia. To investigate the properties of the new blood vessels induced by...
4.
Jackman R, Stapleton T, Masse E, Harvey V, Meyers M, Shockley T, et al.
Hum Gene Ther
. 1998 Jun;
9(7):1069-81.
PMID: 9607418
We have used our previously described ex vivo mesothelial cell (MC)-mediated gene therapy strategy (Gene Ther. 2:393-401, 1995) to modify the functional properties of the rat parietal peritoneal mesothelium in...
5.
Nagy J, Shockley T, Masse E, Harvey V, Hoff C, Jackman R
Gene Ther
. 1995 Aug;
2(6):402-10.
PMID: 7584115
To evaluate the ability of genetically modified peritoneal mesothelial cells to deliver recombinant proteins to the systemic circulation, we used our previously described mesothelial cell-based ex vivo gene therapy strategy....
6.
Nagy J, Shockley T, Masse E, Harvey V, Jackman R
Gene Ther
. 1995 Aug;
2(6):393-401.
PMID: 7584114
We have developed a model system in the rat to test the feasibility of recombinant protein expression by genetically modified peritoneal mesothelial cells following autologous peritoneal implantation. Rat primary peritoneal...
7.
Dvorak A, Weller P, Harvey V, Morgan E, Dvorak H
Int Arch Allergy Immunol
. 1993 Jan;
101(2):136-42.
PMID: 8508051
Subcellular fractions of purified cytoplasmic, nonmembrane-bound lipid bodies were prepared from [3H]-arachidonic acid-labeled guinea pig peritoneal macrophages and line 10 hepatocarcinoma cells. These fractions, which contained [3H]-arachidonyl lipids, were shown...
8.
Brown L, Asch B, Harvey V, Buchinski B, Dvorak H
Cancer Res
. 1988 Apr;
48(7):1920-5.
PMID: 3280123
125I-radiolabeled guinea pig fibrinogen was used to measure the influx (20 min) and accumulation (18 h) of fibrinogen/fibrin in three transplantable carcinomas (Lewis lung, TA3/St mammary, and MOT ovarian) growing...
9.
Brown L, Van de Water L, Harvey V, Dvorak H
Am J Pathol
. 1988 Mar;
130(3):455-65.
PMID: 3279791
Fibrinogen enters wounds and solid tumors, where it is clotted to fibrin that may subsequently be replaced by collagenous stroma. If, as has been suggested, the pathogenesis of wound healing...
10.
Dvorak H, Harvey V, Estrella P, Brown L, McDonagh J, Dvorak A
Lab Invest
. 1987 Dec;
57(6):673-86.
PMID: 2447383
Fibrin deposition is a consistent early event in solid tumors and healing wounds and precedes new blood vessel ingrowth in both. We now demonstrate that fibrin gels of themselves induce...